Skip to main content

Peer Review reports

From: Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study

Original Submission
2 May 2019 Submitted Original manuscript
16 Aug 2019 Reviewed Reviewer Report - Ana W. Capuano
19 Mar 2020 Reviewed Reviewer Report - Giovana Bristot
14 Apr 2020 Author responded Author comments - Oleg A. Levada
20 Apr 2020 Reviewed Reviewer Report - Ana W. Capuano
24 Apr 2020 Author responded Author comments - Oleg A. Levada
Resubmission - Version 2
14 Apr 2020 Submitted Manuscript version 2
28 Apr 2020 Author responded Author comments - Oleg A. Levada
Resubmission - Version 3
28 Apr 2020 Submitted Manuscript version 3
Publishing
30 Apr 2020 Editorially accepted
8 May 2020 Article published 10.1186/s12888-020-02636-7

You can find further information about peer review here.

Back to article page